Thursday - February 26, 2026

Category Archives: Services

Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAGR | Rising Demand for Digital and Direct Ophthalmoscopes Drives Global Expansion, analyses DelveInsight

Ophthalmoscopes Market Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., … Continue reading →

RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Global Sales Momentum Strengthens | DelveInsight

RINVOQ Market The global immunology market is witnessing a significant transformation as RINVOQ (upadacitinib) continues to demonstrate strong prescription growth, expanding indications, and robust revenue performance. DelveInsight’s “RINVOQ Sales Forecast, and Market Size Analysis – 2034” report provides comprehensive insights … Continue reading →

Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight

Electrosurgical Devices Market Electrosurgical Devices Companies in the market include B. Braun Melsungen AG, ConMed Corporation, Olympus Corporation, Apyx Medical Corporation, Medtronic, Johnson & Johnson, Smith & Nephew Plc, Erbe Elektromedizin GmbH, KLS Martin Group, BOWA-electronic GmbH & Co. KG, … Continue reading →

Hypertension Treatment Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Hypertension Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics … Continue reading →

Hepatocellular Carcinoma Clinical Trial Pipeline Shows Potential with Active Contributions from 90+ Key Companies | DelveInsight

DelveInsight’s “Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Hepatitis B Virus Infection Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Hepatitis B Virus Infection Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the Hepatitis B Virus Infection pipeline drug profiles, including clinical and … Continue reading →

Exosomes Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Exosomes Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes Pipeline … Continue reading →